Medico Remedies Profit & Loss Annual

BSE: 540937 | NSE: MEDICO | ISIN: INE630Y01024 | Sector: Biotechnology & Drugs

46.11 +0.67 (1.47%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	144.92	140.44	121.02	122.39
Total Revenue	144.92	140.44	121.02	122.39
Costof Revenue Total	109.91	104.87	87.29	92.18
Gross Profit	35.01	35.57	33.73	30.20
Selling/ General/ Admin Expenses Total	5.92	5.75	5.63	4.50
Depreciation/ Amortization	2.88	2.72	2.08	1.65
Other Operating Expenses Total	16.18	20.19	20.89	20.47
Total Operating Expense	134.89	133.54	115.89	118.81
Operating Income	10.03	6.90	5.13	3.58
Interest Inc( Exp) Net- Non- Op Total	-8.24	36.99	19.30	-1.77
Other Net	2.13	-0.50	-0.51	0.29
Net Income Before Taxes	11.33	10.10	6.55	3.69
Provisionfor Income Taxes	3.04	2.86	1.66	1.09
Net Income After Taxes	8.29	7.24	4.89	2.59
Net Income Before Extra Items	8.29	7.24	4.89	2.59
Net Income	8.29	7.24	4.89	2.59
Income Availableto Com Excl Extra Ord	8.29	7.24	4.89	2.59
Income Availableto Com Incl Extra Ord	8.29	7.24	4.89	2.59
Diluted Net Income	8.29	7.24	4.89	2.59
Diluted Weighted Average Shares	8.29	8.30	8.30	2.07
Diluted EPS Excluding Extra Ord Items	1.00	0.87	0.59	1.25
Diluted Normalized EPS	1.00	0.87	0.59	1.25
Gain( Loss)on Saleof Assets	-	-	-	0.00